Last updated July 14, 2026 Key takeaways The current FDA Wegovy label, revised February 2026, gives injectable semaglutide an elimination half-life of approximately 1 week
We need to acknowledge the complexity of the disease [of obesity] and the complexity of well-managed care, and that the relationship between the two is key. Tracy Zvenyach GLP-1s Are Safe Although GLP-1s have only recently become well-known to the public, they have been used to treat diabetes for 20 years, and there are many studies that show that these drugs are both safe and effective
Integration with Lifestyle Management When combined with diet, exercise, and lifestyle changes, Semaglutide tablets can provide comprehensive support for managing type 2 diabetes and associated risks
Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saille, C., & Ceballos-Picot, I